Author:
Niepel Mario,Hafner Marc,Mills Caitlin E.,Subramanian Kartik,Williams Elizabeth H.,Chung Mirra,Gaudio Benjamin,Barrette Anne Marie,Stern Alan D.,Hu Bin,Korkola James E.,Gray Joe W.,Birtwistle Marc R.,Heiser Laura M.,Sorger Peter K.,Shamu Caroline E.,Jayaraman Gomathi,Azeloglu Evren U.,Iyengar Ravi,Sobie Eric A.,Mills Gordon B.,Liby Tiera,Jaffe Jacob D.,Alimova Maria,Davison Desiree,Lu Xiaodong,Golub Todd R.,Subramanian Aravind,Shelley Brandon,Svendsen Clive N.,Ma’ayan Avi,Medvedovic Mario,Feiler Heidi S.,Smith Rebecca,Devlin Kaylyn
Funder
Thermo Fisher
Micron,
PDX Pharmaceuticals
Susan G. Komen Foundation
Prospect Creek Foundation
NCI
NIH
AztraZeneca
Karus Therapeutics
Nanostring
Pfizer
Tesaro
Adelson Medical Research Foundation
Breast Cancer Research Foundation
Komen Research Foundation
Ovarian Cancer Research Foundation
Subject
Cell Biology,Histology,Pathology and Forensic Medicine
Reference61 articles.
1. Reproducibility will only come with data liberation;AlQuraishi;Sci. Transl. Med.,2016
2. Trial watch: Phase II failures: 2008–2010;Arrowsmith;Nat. Rev. Drug Discov.,2011
3. Towards precision medicine;Ashley;Nat. Rev. Genet.,2016
4. Biotech giant publishes failures to confirm high-profile science;Baker;Nature,2016
5. Review of current methods, applications, and data management for the bioinformatics analysis of whole exome sequencing;Bao;Cancer Inform.,2014